328039
Making our way towards “no wrong door”: Latent classes of substance use disorder treatment facilities in the United States
methods: Using data from 14,056 facilities in the 2012 National Survey of Substance Abuse Treatment Services (N-SSATS), we conducted latent class analyses (LCA) to identify empirically-based clustering. Facility indicators included availability of COD services (e.g. mental health, peer support, COD groups), counseling (e.g. motivational interviewing, cognitive behavioral therapy), and standard practices (e.g. case reviews).
results: LCA indicated a four-class solution as the most parsimonious model with good fit based on fit indices: including: (1) high intensity services (25%) with high probability of endorsing all items; (2) behavioral health services (28%) with lower probability of endorsing non-mental health items; (3) high peer support (20%) with lower probability of endorsing non-peer support items; and (4) low intensity services (27%) with low probability of endorsing all items.
conclusions: Only about half (53%) of facilities were in classes providing behavioral health services. In order to ensure that people with co-occurring behavioral health needs find “no wrong door”, factors acting as facilitators or barriers to incorporating behavioral health services into specialty SUD treatment facilities should be identified.
Learning Areas:
Provision of health care to the publicPublic health or related public policy
Social and behavioral sciences
Learning Objectives:
Identify empirically-derived classes of specialty substance use disorder (SUD) treatment facilities in the US.
Describe classes of specialty SUD treatment facilities by the probability of endorsing service indicators.
Keyword(s): Drug Abuse Treatment, Treatment Patterns
Qualified on the content I am responsible for because: I am a PhD candidate in Drug Dependence Epidemiology at the Johns Hopkins Bloomberg School of Public Health. My research interests include co-occurring behavioral health disorders and health equity.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.